$BUDZ
WEED, INC. Stock $budz

$budz Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000119983523000267 Filed on May 17, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$130.0K	$159.9K	$496.2K
YoY Change	-65.65%	-67.78%	-46.2%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$30.00K	$20.82K	$34.95K
YoY Change	3.99%	-40.44%	4.77%
% of Gross Profit
Operating Expenses	$156.2K	$183.9K	$531.1K
YoY Change	-61.66%	-65.37%	-44.42%
Operating Profit	-$156.2K	-$183.9K	-$531.1K
YoY Change	-61.66%	-65.37%
Interest Expense	$17.28K	$13.11K	-$46.08K
YoY Change	-11.1%	-128.44%	381.5%
% of Operating Profit
Other Income/Expense, Net			-$13.75K
YoY Change			111.86%
Pretax Income	-$170.0K	-$197.0K	-$591.0K
YoY Change	-175.12%	-66.66%	-39.18%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$173.4K	-$197.0K	-$591.0K
YoY Change	-176.64%	-66.66%	-39.18%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$4.928K
COMMON SHARES
Basic Shares Outstanding	123.5M shares	123.5M shares	119.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.00K	$95.75K	$33.89K
YoY Change	-96.35%	182.53%	-22.5%
Cash & Equivalents	$32.47K	$95.75K
Short-Term Investments
Other Short-Term Assets	$3.843K	$3.912K	$17.94K
YoY Change	-78.97%	-78.19%	-94.53%
Inventory
Prepaid Expenses	$18.66K	$19.80K
Receivables	$0.00	$3.910K	$820.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$54.97K	$119.5K	$52.65K
YoY Change	-94.04%	126.89%	-85.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.178M	$1.198M	$1.842M
YoY Change	-8.16%	-34.97%	23.5%
Goodwill	$0.00	$0.00
YoY Change	-100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.253M	$1.277M	$1.882M
YoY Change	-32.34%	-32.15%	22.69%
TOTAL ASSETS
Total Short-Term Assets	$54.97K	$119.5K	$52.65K
Total Long-Term Assets	$1.253M	$1.277M	$1.882M
Total Assets	$1.308M	$1.397M	$1.935M
YoY Change	-52.85%	-27.82%	1.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$151.1K	$163.9K	$232.9K
YoY Change	28.1%	-29.62%	-1.95%
Accrued Expenses	$51.36K	$45.48K	$468.5K
YoY Change	106.27%	-90.29%	32.27%
Deferred Revenue
YoY Change
Short-Term Debt	$730.0K	$679.9K	$853.8K
YoY Change	-18.68%	-20.37%	125.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.445M	$1.396M	$1.556M
YoY Change	-7.02%	-10.31%	60.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.445M	$1.396M	$1.556M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.445M	$1.396M	$1.556M
YoY Change	-7.02%	-10.31%	60.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.73M	-$84.56M
YoY Change	1.84%
Common Stock	$123.5K	$123.5K
YoY Change	0.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$136.7K	$1.111K	$379.1K
YoY Change
Total Liabilities & Shareholders Equity	$1.308M	$1.397M	$1.935M
YoY Change	-52.85%	-27.82%	1.47%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$173.4K	-$197.0K	-$591.0K
YoY Change	-176.64%	-66.66%	-39.18%
Depreciation, Depletion And Amortization	$30.00K	$20.82K	$34.95K
YoY Change	3.99%	-40.44%	4.77%
Cash From Operating Activities	-$100.0K	-$177.2K	-$181.8K
YoY Change	-61.51%	-2.56%	-37.43%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$10.00K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	40.00K	-$32.79K	196.8K
YoY Change	-118.84%	-116.66%	-39.63%
NET CHANGE
Cash From Operating Activities	-100.0K	-$177.2K	-181.8K
Cash From Investing Activities	0.000	-$10.00K
Cash From Financing Activities	40.00K	-$32.79K	196.8K
Net Change In Cash	-60.00K	-$220.0K	$0.00
YoY Change	-107.64%		-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$100.0K	-$177.2K	-$181.8K
Capital Expenditures	$0.00	$10.00K
Free Cash Flow	-$100.0K	-$187.2K	-$181.8K
YoY Change	-61.51%	2.94%	-36.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001393772
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023Q1	us-gaap	Gross Profit GrossProfit		usd
CY2022Q1	us-gaap	Gross Profit GrossProfit		usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses		usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	333-219922
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	WEED, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0452269
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4920 N. Post Trail
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Tucson
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85750
CY2023Q1	dei	City Area Code CityAreaCode	520
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	818-8582
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	123482685	shares
CY2023Q1	us-gaap	Cash Cash	95751	usd
CY2022Q4	us-gaap	Cash Cash	315826	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	19796	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24626	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3912	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1623	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	119459	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	342075	usd
CY2023Q1	us-gaap	Land Land	372069	usd
CY2022Q4	us-gaap	Land Land	372069	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1109931	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1109931	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	147772	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	137772	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1629772	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1619772	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	431758	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	410942	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1198014	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1208830	usd
CY2023Q1	budz	License License	667	usd
CY2022Q4	budz	License License	667	usd
CY2023Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	50000	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	50000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50667	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50667	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12534	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11884	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38133	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38783	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41069	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44130	usd
CY2023Q1	us-gaap	Assets Assets	1396675	usd
CY2022Q4	us-gaap	Assets Assets	1633818	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	163879	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	189779	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45481	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42206	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	420342	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	434750	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	44128	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	42266	usd
CY2023Q1	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	676281	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	706507	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41069	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44130	usd
CY2023Q1	budz	Due To Officers Or Stockholders Current1 DueToOfficersOrStockholdersCurrent1	723	usd
CY2022Q4	budz	Due To Officers Or Stockholders Current1 DueToOfficersOrStockholdersCurrent1	723	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1395564	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1464022	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1395564	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1464022	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123482685	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123482685	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123482685	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123482685	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	123483	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	123483	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83802799	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83796857	usd
CY2023Q1	budz	Subscription Payable SubscriptionPayable	-633750	usd
CY2022Q4	budz	Subscription Payable SubscriptionPayable	-611250	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84558020	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84361006	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-901	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-788	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1111	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	169796	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1396675	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1633818	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	133782	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	136790	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	26096	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	359401	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24030	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34949	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	183908	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	531140	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183908	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-531140	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13106	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	46081	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	13750	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13106	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59831	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-197014	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-590971	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-756	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-197127	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-591727	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123482685	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119927463	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0016
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0049
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	617500	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	813600	usd
CY2022	budz	Imputed Interest On Loans ImputedInterestOnLoans	31722	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1528105	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	777	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	169796	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	22500	usd
CY2023Q1	budz	Imputed Interest On Loans ImputedInterestOnLoans	5942	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-197014	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-113	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1111	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-197014	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-590971	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24030	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34949	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	25018	usd
CY2023Q1	budz	Imputed Interest On Loans ImputedInterestOnLoans	5942	usd
CY2022Q1	budz	Imputed Interest On Loans ImputedInterestOnLoans	9127	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	22500	usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	314200	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2540	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3502	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-25900	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-13001	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9271	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	35350	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177173	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-181826	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	30000	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	480857	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	32789	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	14041	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32789	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	196816	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-219962	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14990	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-113	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-756	usd
CY2022Q4	us-gaap	Cash Cash	315826	usd
CY2021Q4	us-gaap	Cash Cash	19654	usd
CY2023Q1	us-gaap	Cash Cash	95751	usd
CY2022Q1	us-gaap	Cash Cash	33888	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	5113	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_84B_eus-gaap--NatureOfOperations_zx79dUWHCJZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zBJFIVOjwvhd">Nature of Business</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WEED, Inc. (the Company), (formerly United Mines, Inc.) was incorporated under the laws of the State of Arizona on August 20, 1999 (Inception Date) as Plae, Inc. to engage in the exploration of gold and silver mining properties. On November 26, 2014, the Company was renamed from United Mines, Inc. to WEED, Inc. and was repurposed to pursue a business involving the purchase of land, and building Commercial Grade Cultivation Centers to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Companys plan is to become a True Seed-to-Sale company providing infrastructure, financial solutions and real estate options in this new emerging market. The Company, under United Mines, was formerly in the process of acquiring mineral properties or claims located in the State of Arizona, USA. The name was previously changed on February 18, 2005 to King Mines, Inc. and then subsequently changed to United Mines, Inc. on March 30, 2005. The Company trades on the OTC Pink Sheets under the stock symbol: BUDZ.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 20, 2017, the Company acquired Sangre AT, LLC, a Wyoming company doing business as Sangre AgroTech. (Sangre). Sangre is a plant genomic research and breeding company comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available. No work is being conducted now until further funds are available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 2, 2022, the Company acquired Hempirical Genetics, LLC, a Arizona company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a calendar year end for reporting purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_845_eus-gaap--BasisOfAccounting_zQkPNTFvH6Le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zS0qgHuUNOih">Basis of Presentation:</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated balance sheet at December 31, 2022, has been derived from audited consolidated financial statements and the unaudited condensed consolidated financial statements as of March 31, 2023 and 2022 ( the financial statements), have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes. It is managements opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statements presentation. The consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Interim result are not necessarily indicative of results for a full year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zk2sIkDWaYQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_z3vv8CkeIV34">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	4600	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-113	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-756	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84558020	usd
CY2023Q1	budz	Working Capital Deficit WorkingCapitalDeficit	-1276105	usd
CY2023Q1	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	676281	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	706507	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	420342	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	434750	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1629772	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1619772	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	431758	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	410942	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1198014	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1208830	usd
CY2023Q1	us-gaap	Depreciation Depreciation	20817	usd
CY2022Q1	us-gaap	Depreciation Depreciation	34377	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12534	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11884	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	38133	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	38783	usd
CY2023Q1	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38133	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38783	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	650	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	573	usd
CY2023Q1	budz	Notes Payable Related Parties Classified Current Gross NotesPayableRelatedPartiesClassifiedCurrentGross	712000	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current Gross NotesPayableRelatedPartiesClassifiedCurrentGross	744979	usd
CY2023Q1	budz	Loan Fee Net Of Amortization LoanFeeNetOfAmortization	35719	usd
CY2022Q4	budz	Loan Fee Net Of Amortization LoanFeeNetOfAmortization	38472	usd
CY2023Q1	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	676281	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	706507	usd
CY2023Q1	budz	Imputed Interest On Loans ImputedInterestOnLoans	5942	usd
CY2022Q1	budz	Imputed Interest On Loans ImputedInterestOnLoans	9127	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2023Q1	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	0	usd
CY2022Q1	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	487	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	41069	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41069	usd
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	22500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	197014	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1528105	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	17870389	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	197014	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	18067403	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3794155	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3794155	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd

Files In Submission

Name	View Source	Status
0001199835-23-000267-index-headers.html	Edgar Link	pending
0001199835-23-000267-index.html	Edgar Link	pending
0001199835-23-000267.txt	Edgar Link	pending
0001199835-23-000267-xbrl.zip	Edgar Link	pending
budz-10q.htm	Edgar Link	pending
budz-20230331.xsd	Edgar Link	pending
budz-20230331_cal.xml	Edgar Link	unprocessable
budz-20230331_lab.xml	Edgar Link	unprocessable
budz-10q_htm.xml	Edgar Link	completed
budz-ex31_1.htm	Edgar Link	pending
budz-ex31_2.htm	Edgar Link	pending
budz-ex32_1.htm	Edgar Link	pending
budz-ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
budz-20230331_pre.xml	Edgar Link	unprocessable
budz-20230331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BUDZ
WEED, INC. Stock $budz

2023 Q2 Form 10-Q Financial Statement

#000119983523000267 Filed on May 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUDZ WEED, INC. Stock $budz

2023 Q2 Form 10-Q Financial Statement

#000119983523000267 Filed on May 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUDZ
WEED, INC. Stock $budz